Loading…
J.G.Chemicals (JGCHEM)₹597.90+0.87%Commodity Chemicals
In the Jun 2026 quarter (consolidated), J.G.Chemicals reported sales of ₹317 Cr, up 45.1% from Jun 2025, and net profit of ₹25.97 Cr, up 62.4% year on year. For the year to Mar 2026, sales were ₹977 Cr and net profit ₹68.95 Cr.
Company filings, consolidated accounts; latest reported quarter Jun 2026
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 153 | 162 | 182 | 204 | 213 | 210 | 225 | 218 | 221 | 249 | 287 | 317 |
| Expenses | 145 | 147 | 164 | 180 | 191 | 186 | 205 | 198 | 202 | 226 | 265 | 282 |
| Operating Profit | 8.01 | 15.01 | 17.01 | 22.01 | 21.01 | 23.01 | 19.02 | 20.03 | 18.02 | 23.01 | 21.02 | 34.04 |
| OPM % | 5.0% | 9.1% | 9.1% | 11.1% | 10.1% | 11.1% | 9.1% | 9.1% | 8.1% | 9.1% | 8.1% | 11.1% |
| Other Income | −0.99 | 1.99 | 2.99 | 0.00 | 2.99 | 2.99 | 3.99 | 2.99 | 3.99 | 2.99 | 4.98 | 2.99 |
| Interest | 0.99 | 0.99 | 0.99 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 |
| Profit before tax | 5.01 | 15.01 | 18.01 | 20.99 | 23.01 | 23.99 | 21.98 | 21.99 | 20.01 | 25.01 | 25.01 | 35.01 |
| Tax % | 22.0% | 28.0% | 25.0% | 25.0% | 26.0% | 26.0% | 26.0% | 25.0% | 26.0% | 25.0% | 26.0% | 25.0% |
| Exceptional items | −1.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Profit | 3.99 | 11.01 | 13.98 | 16.01 | 16.99 | 17.99 | 15.99 | 15.99 | 14.99 | 17.99 | 18.99 | 25.97 |
| EPS (Rs) | 1.19 | 3.23 | 3.35 | 3.89 | 4.22 | 4.34 | 3.93 | 4.03 | 3.68 | 4.48 | 4.66 | 6.42 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|
| Sales | 399 | 435 | 613 | 784 | 668 | 849 | 977 | 1,074 |
| Expenses | 379 | 390 | 554 | 706 | 620 | 760 | 890 | 974 |
| Operating Profit | 19.99 | 44.05 | 57.02 | 76.05 | 46.03 | 87.08 | 82.06 | 96.09 |
| OPM % | 4.9% | 10.1% | 9.1% | 10.1% | 7.1% | 10.1% | 8.1% | 9.0% |
| Other Income | 7.97 | 4.98 | 9.97 | 9.97 | 5.98 | 9.96 | 15.95 | 14.95 |
| Interest | 6.01 | 4.99 | 6.99 | 5.01 | 3.99 | 0.99 | 1.01 | 0.00 |
| Depreciation | 2.01 | 2.01 | 3.01 | 3.01 | 5.01 | 5.01 | 5.01 | 4.04 |
| Profit before tax | 18.99 | 40.99 | 57.02 | 76.99 | 43.01 | 89.92 | 92.02 | 105 |
| Tax % | 27.0% | 30.0% | 25.0% | 26.0% | 26.0% | 26.0% | 25.0% | — |
| Exceptional items | 0.00 | 1.01 | 1.01 | 1.01 | −1.01 | 1.01 | 0.00 | 0.00 |
| Net Profit | 14.01 | 29.01 | 43.01 | 56.99 | 31.96 | 66.98 | 68.95 | 77.94 |
| EPS (Rs) | 106.61 | 192.56 | 329.08 | 17.36 | 7.90 | 16.39 | 16.85 | 19.24 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 6.0% | 7.0% | — |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 0.99 | 0.99 | 0.99 | 31.91 | 38.88 | 38.89 | 38.88 |
| Reserves | 83.85 | 107 | 151 | 176 | 358 | 425 | 489 |
| Borrowings | 51.88 | 73.80 | 93.81 | 69.82 | 13.96 | 0.00 | 5.98 |
| Other Liabilities | 11.94 | 26.87 | 17.91 | 19.90 | 36.82 | 32.84 | 33.84 |
| Total Liabilities | 149 | 210 | 264 | 297 | 448 | 497 | 568 |
| Fixed Assets | 20.95 | 22.94 | 21.94 | 34.90 | 41.89 | 38.88 | 66.82 |
| CWIP | 0.00 | 0.00 | 6.98 | 0.99 | 0.00 | 0.99 | 7.98 |
| Investments | 6.01 | 9.01 | 8.01 | 3.01 | 43.05 | 51.02 | 136 |
| Other Assets | 123 | 178 | 226 | 259 | 363 | 406 | 358 |
| Inventories | 46.14 | 49.13 | 88.14 | 104 | 56.10 | 111 | 92.17 |
| Trade receivables | 50.06 | 90.05 | 94.97 | 116 | 117 | 142 | 171 |
| Cash & equivalents | 1.01 | 5.01 | 8.01 | 5.01 | 147 | 105 | 38.04 |
| Total Assets | 149 | 210 | 264 | 297 | 448 | 497 | 568 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Cash from operating activity | 41.09 | −7.02 | 7.01 | 31.09 | 76.22 | −11.02 | 44.07 |
| Cash from investing activity | −11.01 | −6.01 | −5.01 | −5.01 | −140 | 25.01 | −59.99 |
| Cash from financing activity | −29.99 | 17.01 | 0.00 | −29.03 | 107 | −29.03 | 0.99 |
| Net cash flow | 0.00 | 3.99 | 0.99 | −1.99 | 42.87 | −14.97 | −14.96 |
| Capex | 4.98 | 4.98 | 8.98 | 9.97 | 8.97 | 4.99 | 38.90 |
| Free cash flow | 35.05 | −13.02 | −2.01 | 21.05 | 67.15 | −16.02 | 5.01 |
| CFO / OP % | 239.0% | 4.0% | 40.1% | 67.1% | 189.1% | 13.1% | 81.1% |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Debtor days | 47 | 77 | 58 | 55 | 65 | 62 | 65 |
| Inventory days | 50 | 52 | 66 | 61 | 38 | 61 | 43 |
| Days payable | 4 | 9 | 5 | 6 | 6 | 10 | 6 |
| Cash conversion cycle | 91 | 119 | 118 | 109 | 96 | 112 | 101 |
| Working capital days | 59 | 72 | 68 | 82 | 96 | 119 | 156 |
| ROCE % | — | 27.0% | 28.0% | 30.0% | 14.0% | 20.0% | 18.0% |
For the Jun 2026 quarter, J.G.Chemicals reported sales of ₹317 Cr, up 45.1% year on year and net profit of ₹25.97 Cr, up 62.4% year on year. The operating margin was 11.1%.
J.G.Chemicals' sales for the year to Mar 2026 were ₹977 Cr; over the last twelve months they were ₹1,074 Cr.
Net profit for the year to Mar 2026 was ₹68.95 Cr, and ₹77.94 Cr over the last twelve months. Earnings per share over the same trailing period were ₹19.24.
J.G.Chemicals reported borrowings of ₹5.98 Cr at Mar 2026, against cash and equivalents of ₹38.04 Cr.
Cash from operations was ₹44.07 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹5.01 Cr.